Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension
Authors:
- Finn GustafssonFGFinn Gustafsson
- Christian Torp-PedersenCTChristian Torp-Pedersen
- Lars KøberLKLars Køber
- Per HildebrandtPHPer Hildebrandt
- 1 July 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 15 (7) , 793-798
Abstract
To evaluate the influence of a history of arterial hypertension on the efficacy of the angiotensin converting enzyme (ACE) inhibitor trandolapril in patients with acute myocardial infarction (AMI) and left ventricular dysfunction. A retrospective analysis of data from the Trandolapril Cardiac Event (TRACE) study. The TRACE study was a randomized, double-blind, placebo-controlled study in which patients with an enzyme-verified AMI and ejection fraction ≤ 35% were assigned randomly to be administered oral trandolapril or placebo 3–7 days after the infarction. Of 1749 patients who entered the study, 400 (23%) had a history of arterial hypertension. The mean follow-up time was 26 months. Mortality from any cause. Secondary endpoints were sudden death, cardiovascular mortality, reinfarction and development of severe heart failure. Of the patients in the hypertensive group, 173 (43%) died during follow-up, versus 500 (37%) in the normotensive group. Treatment with trandolapril resulted in a relative risk of death from any cause for the hypertensive group of 0.59 (95% confidence interval 0.44–0.80), versus 0.85 (0.72–1.02) for normotensive patients. In a multivariate analysis, treatment with trandolapril was associated with a reduction in mortality among patients with a history of hypertension (P = 0.03). In this retrospective analysis, ACE inhibition after AMI complicated with left ventricular dysfunction was of greater benefit to patients with a history of arterial hypertension. ACE inhibition might be of particular importance in this group of patients but further studies to establish the clinical impact are necessary.Keywords
This publication has 19 references indexed in Scilit:
- Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery DiseaseCirculation, 1996
- Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysisJournal Of Hypertension, 1996
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Prognosis in hypertensives with acute myocardial infarctionJournal Of Hypertension, 1992
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Reversal of Left Ventricular Hypertrophy in Hypertensive PatientsAmerican Journal of Hypertension, 1992
- Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure ClinicJournal Of Hypertension, 1990
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTIONThe Lancet, 1988
- Prognosis after acute myocardial infarction: Relation to blood pressure values before infarction in a prospective cardiovascular studyThe American Journal of Cardiology, 1977